These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3840207

  • 1. Surface markers of peripheral blood lymphocytes in Vogt-Koyanagi-Harada disease.
    Okubo K, Kurimoto S, Okubo K, Matsumoto K, Yokoyama MM.
    J Clin Lab Immunol; 1985 May; 17(1):49-52. PubMed ID: 3840207
    [Abstract] [Full Text] [Related]

  • 2. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease.
    Norose K, Yano A, Aosai F, Segawa K.
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1210-6. PubMed ID: 2142146
    [Abstract] [Full Text] [Related]

  • 3. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [Abstract] [Full Text] [Related]

  • 4. [Peripheral lymphocyte subsets in patients with Vogt-Koyanagi-Harada syndrome (VKH)].
    Liu T, Sun SM.
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):138-40. PubMed ID: 8223036
    [Abstract] [Full Text] [Related]

  • 5. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
    Norose K, Yano A, Wang XC, Tokushima T, Umihira J, Seki A, Nohara M, Segawa K.
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
    [Abstract] [Full Text] [Related]

  • 6. [Lymphocyte subsets in peripheral blood and cerebrospinal fluid in Vogt-Koyanagi-Harada disease].
    Kuwasaki N, Shoji H, Kaji M, Matsumoto K, Yokoyama M.
    Rinsho Shinkeigaku; 1985 Aug; 25(8):956-9. PubMed ID: 4064437
    [No Abstract] [Full Text] [Related]

  • 7. Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis.
    Yokoyama MM, Matsui Y, Yamashiroya HM, O'Donnell MJ, Tseng CH, Snyder DA, Tessler HH, Crispen RG, Zimjewski CM.
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):364-70. PubMed ID: 7203881
    [Abstract] [Full Text] [Related]

  • 8. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
    Liu L, Yang P, He H, Lin X, Jiang L, Chi W, Zhao C, Zhou H.
    Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271
    [Abstract] [Full Text] [Related]

  • 9. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
    Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
    [Abstract] [Full Text] [Related]

  • 10. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
    Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A.
    J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
    [Abstract] [Full Text] [Related]

  • 11. Cell mediated immunity to human myelin basic protein in Vogt-Koyahagi-Harada syndrome.
    Manor RS, Livni E, Cohen S.
    Invest Ophthalmol Vis Sci; 1979 Feb; 18(2):204-6. PubMed ID: 83972
    [Abstract] [Full Text] [Related]

  • 12. [Immunological studies on lymphocytes in the cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease and sympathetic ophthalmia].
    Ariga H, Ohno S, Higuchi M, Matsuda H.
    Nippon Ganka Gakkai Zasshi; 1988 Feb; 92(2):225-8. PubMed ID: 3389270
    [No Abstract] [Full Text] [Related]

  • 13. Requirement of Ia-positive nylon wool adherent cells for activation of cytotoxic T-lymphocytes specific to melanocyte-associated antigens in patients with Vogt-Koyanage-Harada's disease.
    Maezawa N, Yano A.
    Jpn J Ophthalmol; 1988 Feb; 32(3):348-57. PubMed ID: 3265967
    [Abstract] [Full Text] [Related]

  • 14. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease.
    Kogiso M, Tanouchi Y, Miki S, Mimura Y.
    Jpn J Ophthalmol; 1992 Feb; 36(1):37-43. PubMed ID: 1635294
    [Abstract] [Full Text] [Related]

  • 15. Distribution of marker-specific lymphocyte subsets in healthy human subjects.
    Matsumoto K, Okubo K, Yokoyama MM.
    J Clin Lab Immunol; 1985 Mar; 16(3):143-7. PubMed ID: 3897544
    [Abstract] [Full Text] [Related]

  • 16. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease.
    Maezawa N, Yano A, Taniguchi M, Kojima S.
    Ophthalmologica; 1982 Mar; 185(3):179-86. PubMed ID: 6982444
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.
    Inomata H, Sakamoto T.
    Curr Eye Res; 1990 Mar; 9 Suppl():35-40. PubMed ID: 1974489
    [Abstract] [Full Text] [Related]

  • 18. Vogt-koyanagi-harada syndrome.
    Fang W, Yang P.
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [Abstract] [Full Text] [Related]

  • 19. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
    Yang Y, Xiao X, Li F, Du L, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1012-7. PubMed ID: 22247488
    [Abstract] [Full Text] [Related]

  • 20. CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
    El-Asrar AM, Al-Obeidan SS, Kangave D, Geboes K, Opdenakker G, Van Damme J, Struyf S.
    Immunobiology; 2011 Sep 27; 216(9):1004-9. PubMed ID: 21531038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.